BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10520809)

  • 1. Angiotensin I-converting enzyme and plasminogen activator inhibitor-1 gene variants: risk of mortality and fatal cardiovascular disease in an elderly population-based cohort.
    Heijmans BT; Westendorp RG; Knook DL; Kluft C; Slagboom PE
    J Am Coll Cardiol; 1999 Oct; 34(4):1176-83. PubMed ID: 10520809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4G/4G genotype of PAI-1 gene is associated with reduced risk of stroke in elderly.
    Hoekstra T; Geleijnse JM; Kluft C; Giltay EJ; Kok FJ; Schouten EG
    Stroke; 2003 Dec; 34(12):2822-8. PubMed ID: 14605330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
    Jastrzebska M; Widecka K; Ciechanowicz A; Goracy I; Wesołowska T; Torbus-Lisiecka B; Foltyńska-Nowakowska A; Naruszewicz M
    Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes.
    Margaglione M; Grandone E; Vecchione G; Cappucci G; Giuliani N; Colaizzo D; Celentano E; Panico S; Di Minno G
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2082-7. PubMed ID: 9351375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
    Nowakowska A
    Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.
    Kimura H; Gejyo F; Suzuki Y; Suzuki S; Miyazaki R; Arakawa M
    Kidney Int; 1998 Nov; 54(5):1659-69. PubMed ID: 9844142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAI-1 4G/5G and ACE I/D gene polymorphisms and the occurrence of myocardial infarction in patients on intermittent dialysis.
    Aucella F; Margaglione M; Vigilante M; Gatta G; Grandone E; Forcella M; Ktena M; De Min A; Salatino G; Procaccini DA; Stallone C
    Nephrol Dial Transplant; 2003 Jun; 18(6):1142-6. PubMed ID: 12748347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme D/I and plasminogen activator inhibitor-1 4G/5G gene polymorphisms are associated with increased risk of spontaneous abortions in polycystic ovarian syndrome.
    Sun L; Lv H; Wei W; Zhang D; Guan Y
    J Endocrinol Invest; 2010 Feb; 33(2):77-82. PubMed ID: 19636212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients.
    Wong TY; Poon P; Szeto CC; Chan JC; Li PK
    Kidney Int; 2000 Feb; 57(2):632-8. PubMed ID: 10652041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients.
    Prisco D; Fatini C; Battaglini B; Gensini F; Fedi S; Falai M; Chioccioli M; Gori AM; Margheri M; Gensini GF
    Int J Clin Lab Res; 2000; 30(4):179-85. PubMed ID: 11289708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype combinations of plasminogen activator inhibitor-1 and angiotensin-converting enzyme genes and risk for early onset of coronary heart disease.
    Loew M; Hoffmann MM; Hahmann H; Maerz W; Brenner H; Rothenbacher D
    Eur J Cardiovasc Prev Rehabil; 2006 Jun; 13(3):449-56. PubMed ID: 16926677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of ACE (I/D) and PAI-1 (4G/5G) gene variants in recurrent miscarriage in Polish population.
    Kurzawińska G; Barlik M; Drews K; Różycka A; Seremak-Mrozikiewicz A; Ożarowski M; Klejewski A; Czerny B; Wolski H
    Ginekol Pol; 2016; 87(4):271-6. PubMed ID: 27321098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Incidence of ACE/PAI-1 in Association to a Spectrum of Other Polymorphic Cardiovascular Genes Involving PBMCs Proinflammatory Cytokines in Hypertensive Hypercholesterolemic Patients: Reversibility with a Combination of ACE Inhibitor and Statin.
    AlBacha Jd; Khoury M; Mouawad C; Haddad K; Hamoui S; Azar A; Fajloun Z; Makdissy N
    PLoS One; 2015; 10(5):e0127266. PubMed ID: 25973747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism and synergism of angiotensin-converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) genes in coronary artery disease.
    Sakhteh M; Poopak B; Amirizadeh N; Shamshiri A; Bagheri A; Faranoush M
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1168-74. PubMed ID: 25501306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator inhibitor-1 and angiotensin converting enzyme gene polymorphisms in Turkish asthmatic children.
    Bora E; Soylar R; Arıkan-Ayyıldız Z; Uzuner N; Giray-Bozkaya Ö; Erçal D; Karaman Ö; Ülgenalp A
    Allergol Immunopathol (Madr); 2013; 41(1):11-6. PubMed ID: 22361338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor 4G polymorphism is associated with decreased risk of cerebrovascular mortality in older women.
    Roest M; van der Schouw YT; Banga JD; Tempelman MJ; de Groot PG; Sixma JJ; Grobbee DE
    Circulation; 2000 Jan 4-11; 101(1):67-70. PubMed ID: 10618306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinations of fibrinolytic gene polymorphisms (plasminogen activator inhibitor type 1 4G/5G, factor XIII Val34Leu and angiotensin-converting enzyme I/D) in women with idiopathic infertility.
    Velickovic J; Jelicic M; Stojkovic O
    Blood Coagul Fibrinolysis; 2021 Mar; 32(2):103-107. PubMed ID: 33555692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PAI-1 4G/5G and ACE I/D polymorphisms and risk of recurrent pregnancy loss: a case-control study.
    Kim JJ; Choi YM; Lee SK; Yang KM; Paik EC; Jeong HJ; Jun JK; Han AR; Hong MA
    Am J Reprod Immunol; 2014 Dec; 72(6):571-6. PubMed ID: 25078885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of ACE I/D, AT1R A1166C, PAI-I 4G/5G and GPIIIa a1/a2 polymorphisms in myocardial infarction.
    Martínez-Quintana E; Chirino R; Nieto-Lago V; Pérez-Jiménez P; López-Ríos L; Rodríguez-González F
    Cardiol J; 2014; 21(3):229-37. PubMed ID: 23990179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are polymorphisms in the ACE and PAI-1 genes associated with recurrent spontaneous miscarriages?
    Goodman C; Hur J; Goodman CS; Jeyendran RS; Coulam C
    Am J Reprod Immunol; 2009 Dec; 62(6):365-70. PubMed ID: 19821806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.